Last 12 months
Inside the activity.
0 purchase rows · 169 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 23 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 44 |
| Feb 2026 | 0 | 22 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 19 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 06, 2026 Filed Apr 8, 2026 20:41 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 787 | $161.73 | $127,281.51 |
DisclosureSEC source: 0001402051-26-000022 · wk-form4_1775680879.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 311,097 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 787 shares sold at prices ranging from $161.65 to $162.58 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| April 06, 2026 Filed Apr 8, 2026 20:41 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 4,440 | $17.16 | $76,190.40 |
DisclosureSEC source: 0001402051-26-000022 · wk-form4_1775680879.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 311,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| April 06, 2026 Filed Apr 8, 2026 20:41 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 6,259 | $30.46 | $190,649.14 |
DisclosureSEC source: 0001402051-26-000022 · wk-form4_1775680879.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 307,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:07 UTC |
Adsett RogerChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 88,060 | $0.00 Strike: $14.56 | $0.00 |
DisclosureSEC source: 0001685904-26-000008 · wk-form4_1775246852.xml · derivative · entry 5 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 88,060 shares Expires 2026-10-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:07 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 62,344 | $164.95 | $10,283,642.80 |
DisclosureSEC source: 0001685904-26-000008 · wk-form4_1775246852.xml · nonDerivative · entry 4 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,810 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 62,344 shares sold at prices ranging from $164.52 to $165.45 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:07 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 19,001 | $164.11 | $3,118,254.11 |
DisclosureSEC source: 0001685904-26-000008 · wk-form4_1775246852.xml · nonDerivative · entry 3 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 169,154 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 19,001 shares sold at prices ranging from $163.52 to $164.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:07 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 6,715 | $163.18 | $1,095,753.70 |
DisclosureSEC source: 0001685904-26-000008 · wk-form4_1775246852.xml · nonDerivative · entry 2 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 188,155 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 6,715 shares sold at prices ranging from $162.52 to $163.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:07 UTC |
Adsett RogerChief Operating Officer
|
Exercise / conversionCommon Stock | 88,060 | $14.56 | $1,282,153.60 |
DisclosureSEC source: 0001685904-26-000008 · wk-form4_1775246852.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 194,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 30, 2026 Filed Mar 31, 2026 20:13 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,989 | $0.00 Strike: $27.89 | $0.00 |
DisclosureSEC source: 0001870278-26-000010 · wk-form4_1774988003.xml · derivative · entry 5 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,561 Underlying: Common Stock · 13,989 shares Expires 2031-07-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 30, 2026 Filed Mar 31, 2026 20:13 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,649 | $0.00 Strike: $17.07 | $0.00 |
DisclosureSEC source: 0001870278-26-000010 · wk-form4_1774988003.xml · derivative · entry 4 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,633 Underlying: Common Stock · 5,649 shares Expires 2032-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 30, 2026 Filed Mar 31, 2026 20:13 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 19,638 | $150.98 | $2,964,945.24 |
DisclosureSEC source: 0001870278-26-000010 · wk-form4_1774988003.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,871 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 30, 2026 Filed Mar 31, 2026 20:13 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionCommon Stock | 13,989 | $27.89 | $390,153.21 |
DisclosureSEC source: 0001870278-26-000010 · wk-form4_1774988003.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 30, 2026 Filed Mar 31, 2026 20:13 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionCommon Stock | 5,649 | $17.07 | $96,428.43 |
DisclosureSEC source: 0001870278-26-000010 · wk-form4_1774988003.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 19, 2026 Filed Mar 20, 2026 20:05 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,440 | $0.00 Strike: $17.16 | $0.00 |
DisclosureSEC source: 0001402051-26-000020 · wk-form4_1774037117.xml · derivative · entry 8 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,520 Underlying: Common Stock · 4,440 shares Expires 2027-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 19, 2026 Filed Mar 20, 2026 20:05 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,259 | $0.00 Strike: $30.46 | $0.00 |
DisclosureSEC source: 0001402051-26-000020 · wk-form4_1774037117.xml · derivative · entry 7 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,073 Underlying: Common Stock · 6,259 shares Expires 2028-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 19, 2026 Filed Mar 20, 2026 20:05 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 4,533 | $144.11 | $653,250.63 |
DisclosureSEC source: 0001402051-26-000020 · wk-form4_1774037117.xml · nonDerivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 301,185 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 4,533 shares sold at prices ranging from $143.80 to $144.72 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 19, 2026 Filed Mar 20, 2026 20:05 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 4,537 | $143.42 | $650,696.54 |
DisclosureSEC source: 0001402051-26-000020 · wk-form4_1774037117.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 305,718 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 4,537 shares sold at prices ranging from $142.80 to $143.77 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 19, 2026 Filed Mar 20, 2026 20:05 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 1,629 | $142.17 | $231,594.93 |
DisclosureSEC source: 0001402051-26-000020 · wk-form4_1774037117.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 310,255 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 1,629 shares sold at prices ranging from $141.80 to $142.74 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 19, 2026 Filed Mar 20, 2026 20:05 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 4,440 | $17.16 | $76,190.40 |
DisclosureSEC source: 0001402051-26-000020 · wk-form4_1774037117.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 311,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 19, 2026 Filed Mar 20, 2026 20:05 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 6,259 | $30.46 | $190,649.14 |
DisclosureSEC source: 0001402051-26-000020 · wk-form4_1774037117.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 307,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,440 | $0.00 Strike: $17.16 | $0.00 |
DisclosureSEC source: 0001402051-26-000018 · wk-form4_1772745408.xml · derivative · entry 9 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,960 Underlying: Common Stock · 4,440 shares Expires 2027-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,259 | $0.00 Strike: $30.46 | $0.00 |
DisclosureSEC source: 0001402051-26-000018 · wk-form4_1772745408.xml · derivative · entry 8 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,332 Underlying: Common Stock · 6,259 shares Expires 2028-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 2,128 | $147.54 | $313,965.12 |
DisclosureSEC source: 0001402051-26-000018 · wk-form4_1772745408.xml · nonDerivative · entry 6 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 301,185 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 2,128 shares sold at prices ranging from $147.15 to $148.04 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F6 · balance_after: The Reporting Person no longer has a reportable beneficial interest in the securities owned by the William Lewis Family Legacy Trust, which were included in the Reporting Person's prior ownership reports. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 3,899 | $146.66 | $571,827.34 |
DisclosureSEC source: 0001402051-26-000018 · wk-form4_1772745408.xml · nonDerivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 303,313 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 3,899 shares sold at prices ranging from $146.09 to $147.06 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 2,589 | $145.27 | $376,104.03 |
DisclosureSEC source: 0001402051-26-000018 · wk-form4_1772745408.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 307,212 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 2,589 shares sold at prices ranging from $144.99 to $145.78 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 2,083 | $144.23 | $300,431.09 |
DisclosureSEC source: 0001402051-26-000018 · wk-form4_1772745408.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 309,801 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 2,083 shares sold at prices ranging from $143.84 to $144.70 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 4,440 | $17.16 | $76,190.40 |
DisclosureSEC source: 0001402051-26-000018 · wk-form4_1772745408.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 311,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 21:16 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 6,259 | $30.46 | $190,649.14 |
DisclosureSEC source: 0001402051-26-000018 · wk-form4_1772745408.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 307,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 21:15 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001182633-26-000006 · wk-form4_1772745307.xml · nonDerivative · entry 1 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,776 Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:14 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 243 | $0.00 | $0.00 |
DisclosureSEC source: 0001182633-26-000003 · wk-form4_1772226888.xml · nonDerivative · entry 5 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Melvin Sharoky C/F Adler J. Wink UTMA/FL Disclosed balance after: 819 F4 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Adler J. Wink UTMA/FL. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:14 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 243 | $0.00 | $0.00 |
DisclosureSEC source: 0001182633-26-000003 · wk-form4_1772226888.xml · nonDerivative · entry 4 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Melvin Sharoky C/F Sophie C. Wink UTMA/FL Disclosed balance after: 5,007 F3 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:14 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 243 | $0.00 | $0.00 |
DisclosureSEC source: 0001182633-26-000003 · wk-form4_1772226888.xml · nonDerivative · entry 3 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL Disclosed balance after: 3,724 F2 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:14 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 243 | $0.00 | $0.00 |
DisclosureSEC source: 0001182633-26-000003 · wk-form4_1772226888.xml · nonDerivative · entry 2 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Melvin Sharoky C/F Nolan M. Wink UTMA/FL Disclosed balance after: 5,423 F1 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Nolan M. Wink UTMA/FL. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:14 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 1,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001182633-26-000003 · wk-form4_1772226888.xml · nonDerivative · entry 1 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,876 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:04 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,248 | $0.00 Strike: $17.07 | $0.00 |
DisclosureSEC source: 0001870278-26-000008 · wk-form4_1772053483.xml · derivative · entry 5 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,282 Underlying: Common Stock · 20,248 shares Expires 2032-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:04 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 15,771 | $156.53 | $2,468,634.63 |
DisclosureSEC source: 0001870278-26-000008 · wk-form4_1772053483.xml · nonDerivative · entry 4 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,871 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 15,771 shares sold at prices ranging from $156.00 to $156.86 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:04 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 4,151 | $155.06 | $643,654.06 |
DisclosureSEC source: 0001870278-26-000008 · wk-form4_1772053483.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,642 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 4,151 shares sold at prices ranging from $154.47 to $155.45 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:04 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 4,852 | $153.93 | $746,868.36 |
DisclosureSEC source: 0001870278-26-000008 · wk-form4_1772053483.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,793 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 4,852 shares sold at prices ranging from $153.47 to $154.46 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:04 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionCommon Stock | 20,248 | $17.07 | $345,633.36 |
DisclosureSEC source: 0001870278-26-000008 · wk-form4_1772053483.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:04 UTC |
Brennan David RDirector
|
GiftCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001609305-26-000002 · wk-form4_1772053457.xml · nonDerivative · entry 1 Brennan David R · CIK 0001609305 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,933 Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:34 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,440 | $0.00 Strike: $17.16 | $0.00 |
DisclosureSEC source: 0001402051-26-000015 · wk-form4_1771882447.xml · derivative · entry 11 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,400 Underlying: Common Stock · 4,440 shares Expires 2027-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:34 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,259 | $0.00 Strike: $30.46 | $0.00 |
DisclosureSEC source: 0001402051-26-000015 · wk-form4_1771882447.xml · derivative · entry 10 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,591 Underlying: Common Stock · 6,259 shares Expires 2028-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:34 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 1,030 | $153.38 | $157,981.40 |
DisclosureSEC source: 0001402051-26-000015 · wk-form4_1771882447.xml · nonDerivative · entry 7 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 301,185 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: This is the weighted average sales price representing 1,030 shares sold at prices ranging from $153.00 to $153.78 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:34 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 2,377 | $151.92 | $361,113.84 |
DisclosureSEC source: 0001402051-26-000015 · wk-form4_1771882447.xml · nonDerivative · entry 6 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 302,215 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 2,377 shares sold at prices ranging from $151.56 to $152.43 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:34 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 3,413 | $151.12 | $515,772.56 |
DisclosureSEC source: 0001402051-26-000015 · wk-form4_1771882447.xml · nonDerivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 304,592 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 3,413 shares sold at prices ranging from $150.54 to $151.51 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:34 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 1,891 | $150.10 | $283,839.10 |
DisclosureSEC source: 0001402051-26-000015 · wk-form4_1771882447.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 308,005 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 1,891 shares sold at prices ranging from $149.53 to $150.50 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:34 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 1,988 | $149.17 | $296,549.96 |
DisclosureSEC source: 0001402051-26-000015 · wk-form4_1771882447.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 309,896 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 1,988 shares sold at prices ranging from $148.51 to $149.50 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:34 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 4,440 | $17.16 | $76,190.40 |
DisclosureSEC source: 0001402051-26-000015 · wk-form4_1771882447.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 311,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:34 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 6,259 | $30.46 | $190,649.14 |
DisclosureSEC source: 0001402051-26-000015 · wk-form4_1771882447.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 307,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:43 UTC |
MCGIRR DAVID W JDirector
|
GiftCommon Stock | 53,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001219023-26-000002 · wk-form4_1770846185.xml · nonDerivative · entry 2 MCGIRR DAVID W J · CIK 0001219023 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By family trust Disclosed balance after: 53,400 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.